Dianthus Therapeutics Inc - DNTH Market Valuation

Dianthus Therapeutics specializes in developing precision therapies for inflammatory pathologies by targeting the complement system, generating revenue through partnership agreements and grants. Development stability is supported by a sufficient liquidity reserve, which mitigates the risks of rapid cash burn during the study of rare diseases. The share price illustrated below, which currently stands at 5.16, confirms the synergy derived from alliances with biotech laboratories.

Dianthus Therapeutics, Inc. - DNTH Market Value (period 02/21/2024 - 11/14/2026)

Comprehensive metric breakdowns and analytics for Dianthus Corp (DNTH)

- market price and analyst price targets:

Price Chart Dianthus Therapeutics, Inc.|DNTH - Broker Consensus Forecast

- issuer market value details:

Market Valuation Dianthus Corp|DNTH - Aggregate Business Value

- business book valuation details:

Book Value per Share Dianthus Therapeutics|DNTH - Accounting Value of Company|Market Value to Book Value Ratio dianthustx.com|DNTH - Total Asset Value of Company

- debt obligations and liquidity statistics:

Total Debt to Capital Dianthus Therapeutics|DNTH - Long-Term Debt to Capital Coefficient|Short-Term Debt to Capital Dianthus Therapeutics|DNTH - Company Aggregate Debts|Debt to Book Capitalization Ratio Dianthus Corp|DNTH - Company Long-Term Loans and Borrowings|Company Short-Term Debt Dianthus Therapeutics|Quick Ratio dianthustx.com

- financial results and valuation multiples details:

DNTH - Net Profit|Future Profit Dianthus Therapeutics|DNTH - Company Value to Net Income|Forward P/E Multiple Dianthus Pharma|DNTH - Growth-Adjusted Market Cap to Net Income|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization Dianthus Corp|DNTH - Operating profit before deduction of amortization|Earnings per share for the last twelve months Dianthus Therapeutics|DNTH - Net earnings per share for the last 12 months|Year-over-year net earnings per share growth for the last 12 months dianthustx.com|DNTH - Earnings growth in current year|Net earnings per share growth forecast for next year Dianthus Therapeutics

- company sales and revenue statistics:

DNTH - Company Sales Volume|Projected Sales Volume Dianthus Therapeutics, Inc.|DNTH - Price to Sales|Forward P/S Multiple Dianthus Corp

Fundamental company analysis:DNTH (Dianthus Therapeutics, Inc.)

Market capitalization measures the aggregate value of shares, reflecting the discounted value of future cash flows while accounting for the impact of interest rates on the cost of debt. The trend in the total capitalization of Dianthus Therapeutics (DNTH) demonstrates the company's sensitivity to geopolitical risks, where restricted access to international clinical sites and scientific protectionism could lead to a revaluation of the business's fundamental value.

Key competitors